|
ABX advanced biochemical compounds |
|
History |
|
| 1997: |
Foundation of ABX GmbH Vision: Production of PET Precursor |
| 1998: |
Start with own laboratory ( 30 sqm ) Start with CRO business |
| 2001: | Start of kit production in new facilities in Robert-Bosch-Strasse |
| 2002: |
Split off of CRO business into independent ABX-CRO GmbH Purchase of facilities in Heinrich-Glaeser-Strasse 10 - 14 and start of reconstruction |
| 2003: |
Chemical labs and clean rooms in Heinrich-Glaeser-Strasse 12 operational |
| 2004: |
Successful audit by “Regierungspraesidium Dresden” for GMP production |
| 2005: |
Successful audit by FDA for GMP compliance for APIs Successful audit by “Regierungspräsidium Dresden” for license of wholesalers |
| 2006: |
Change in ownership - new owner: CIL / Cambridge Isotope Laboratories,
Inc. (USA), subsidiary of Otsuka Pharmaceuticals (Japan))
|
| 2007: |
Hot (radiosynthesis) laboratory for R&D in Heinrich-Glaeser-Strasse 10 operational
re-audit by “Regierungspraesidium Dresden” for GMP production |
| 2008: | Re-audit by FDA for GMP compliance for APIs |
| 2010: | New production building for filling and assembling in Heinrich-Glaeser-Strasse 14 operational |
|
legal notice home page search email ICP License: 沪ICP备05000469号-1 |
|